FierceBiotech ١٤ مايو ٢٠٢٦ BioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS
Merck & Co. ١٤ مايو ٢٠٢٦ AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda - Fierce Pharma
Merck & Co. ١٤ مايو ٢٠٢٦ Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Thermo Fisher ١٤ مايو ٢٠٢٦ Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher - Contract Pharma
Eli Lilly ١٤ مايو ٢٠٢٦ Eli Lilly delivers $50M boost to UNICEF’s pediatric health push - Fierce Pharma
FierceBiotech ١٤ مايو ٢٠٢٦ Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?
Qiagen ١٤ مايو ٢٠٢٦ Qiagen stock (NL0012169213): Dividend announced as FY guidance slashed - AD HOC NEWS
Promega Blog ١٤ مايو ٢٠٢٦ Charged Molecular Glues: The Molecular Trojan Horse That Slipped Past Biology’s Toughest Bouncer
Amgen ١٤ مايو ٢٠٢٦ Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS